Clin2
NCT07025980Possibly a fitNot yet recruiting

Probiotics for fatty liver disease

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertensionHyperlipidaemia

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests whether a special mix of probiotics can help improve liver health in people with fatty liver disease related to metabolism. It measures changes in liver enzymes, fat, and stiffness over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
114 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have fatty liver disease confirmed by ultrasound or a special scan.
  • You have metabolic syndrome: a waist size over 80 cm (women) or 94 cm (men), plus at least two of the following: high blood pressure, high blood sugar, abnormal cholesterol or triglycerides.
  • You do not drink more than 30 grams of alcohol per day (men) or 20 grams per day (women).
  • You do not have other liver diseases like hepatitis or cirrhosis.
  • You have not taken antibiotics or probiotics in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06845345Enrolling by invitation· Phase 4
Can a special diet or pills help liver health?

This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.

Rotterdam
NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT07400367Recruiting
Probiotics and lifestyle changes for fatty liver disease

This trial tests whether taking probiotics plus making lifestyle changes can improve fatty liver and metabolic health. You may qualify if you have liver fat and at least one sign of metabolic problems like high blood sugar or high blood pressure.

New Taipei City
NCT06873165Recruiting
Gut bacteria treatment for fatty liver disease

This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.

Taipei
NCT06585982Recruiting
Synbiotics for MAFLD: gut health and liver fat study

This trial tests whether taking a synbiotic (a mix of helpful bacteria and fiber) can improve insulin levels and reduce inflammation in people with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). It may help by changing the balance of bacteria in your gut.

Semarang, Semarang
NCT06563921Not yet recruiting
Probiotics for fatty liver disease

This study tests whether probiotics and a specific exercise program can help people with fatty liver disease, including the inflammatory type. It aims to see if these treatments can improve liver health.

Hear when a new Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.